The World Health Organization (WHO) Ebola emergency committee that met today to review the outbreak situation in the Democratic Republic of the Congo (DRC) recommended continuing the public health emergency of international concern under International Health Regulations.
Candida auris formed biofilms that were 10 times as dense as those formed by C albicans.
The authors say the finding is concerning and emphasize the role of repeat susceptibility tests.
The Agency for Healthcare Research and Quality (AHRQ) has released a new toolkit to improve antibiotic use in acute care hospitals.
Resistant bacteria and fungi cause more than 2.8 million infections and 35,000 deaths a year in the United States, a new report says.
The US Centers for Disease Control and Prevention (CDC) announced yesterday that the Pan American Health Organization (PAHO)/World Health Organization (WHO) have designated the CDC's Center for Global Health as a PAHO/WHO Collaborating Center for Biosafety and Biosecurity.
A study conducted in Dutch hospitals has found that an isolation strategy of contact precautions in a multiple-bed hospital room was non-inferior to a strategy of contact precautions in a single-bed room for preventing the spread of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae, Dutch researchers reported in The Lancet Infectious Diseases.
Could climate change have played a role in the emergence of the multidrug-resistant fungus Candida auris?
The US Food and Drug Administration (FDA) today announced the approval of Recarbrio, a new three-drug antibacterial product developed by Merck, for treating patients with complicated urinary tract infections (cUTIs) and complicated intra-abdominal infections (cIAIs) caused by gram-negative pathogens.
The number of confirmed and probable cases of the multidrug-resistant fungus Candida auris in the United States rose to 716 as of May 31, reflecting an increase of 32, the US Centers for Disease Control and Prevention (CDC) said in its most recent case-count update.
